A long-term care crisis is brewing around the world: who will provide and pay for LTC?
By 2050, the demand for long-term care (LTC) workers will more than double in the developed world, from Norway and New Zealand to Japan and the U.S. Aging populations with growing incidence of disabilities, looser family ties, and more women in the labor force are driving this reality. This is a multi-dimensional problem which requires looking beyond the issue of the simple aging demographic. Help Wanted? is an apt title for the report from The Organization of Economic Cooperation and Development (OECD), subtitled, “providing and paying for long-term care.” The report details the complex forces exacerbating the LTC carer shortage, focusing
Most Americans like the idea “Big Government” when it comes to food safety
Two-thirds of Americans favor increasing funding to the Food & Drug Administration (FDA) to ensure food safety in the U.S. Furthermore, 9 in 10 Americans also believe that the Federal government should be responsible for ensuring that food is safe to eat. And, 3 in 4 Americans say if it costs 1 to 3% more money to buy safer foods. they’d be willing to pay for those foods kept safer by the new food safety measures. A poll from the Pew Charitable Trusts, conducted by Hart Research Associates in April and May 2011, finds that when it comes to what Americans eat,
Patients feel out of the Rx drug development process: why participatory health in pharma is important
“Value” in prescription drugs is first and foremost about outcomes, in the eyes of physicians and biopharma. For managed care, “value” is first about safety, then patient outcomes. However, although one-third of patients managing a chronic condition cannot define “value” in health care, 9 in 10 say that prescription drugs are “valuable” to their health and wellbeing. In fact, 80% say that the money they spend on prescription medications is “worth it.” Yet patients feel largely out of the prescription drug development process. These findings come from Quintiles research report, The 2011 New Health Report, subtitled: exploring perceptions of value and collaborative relationships among
Health care where we live, play, work and pray: how Ford & Toyota’s mhealth pilots fit into Whole Health
In an interview in March 2011 with the Los Angeles Times, Dr. Regina Benjamin, the U.S. Surgeon General, said, “We can’t look at health in isolation. It’s not just in the doctor’s office. It’s got to be where we live, we work, we play, we pray. If you have a healthy community, you have a healthy individual.” Ford’s announcement last week that the automaker would team up with WellDoc to incorporate mobile health sensors into the company’s SYNC connectivity system follows Toyota’s mhealth concept, the RiN, launched in 2007. Among various applications envisioned at this preliminary stage: Glucose monitors, from Medtronic, will
Don’t assume generics will stop drug cost trends in 2012 and beyond: specialty drugs will drive growing Rx spending
In the 2011 Medco Drug Trend Report, there’s good news and bad news depending on the lens you wear as a health care stakeholder in the U.S. On the positive side of the ledger, for consumers, payers and health plan sponsors, drug trend in 2010 stayed fairly flat at 3.7% growth. That’s due in major part to the increasing roster of generic drugs taking the place of aging branded prescriptions products. More than $100 billion (with a ‘b’) worth of branded drugs will go off-patent between 2010 and 2020, and the generic dispensing rate could reach 85% by 2020, Medco
Working past 70 is the new retirement
American workers are worried about outliving their savings and not being able to meet the financial needs of their families, according to The 12th Annual Retirement Survey from the Transamerica Center for Retirement Studies. The study paints a picture of 4,080 U.S. workers who forecast insecure financial futures. Their personal portraits find them working into older ages than they had previously expected to — before the recession. 54% of workers plan to work in retirement. 39% of workers will retire after age 70, or not at all. It’s not only Baby Boomers who expect to work past 65. Two-thirds of workers in their
Patient perspectives should be part of evidence-based medicine, Dr. Weil et al say
Randomized controlled trials (RCTs) have been the rational cornerstone of medical decision making for decades. RCTs demonstrate a drug or therapeutic course’s efficacy – that is, the extent to which a specific intervention, procedure, or regimen produces a beneficial result under ideal conditions. Of course, how a particular therapy works in an individual is highly personalized based not only on a body’s biochemistry, but personal preferences, perceptions, and personality. That’s why Dr. Andrew Weil and his colleagues, Dr. Scott Shannon and Dr. Bonnie Kaplan, say that medical decision making should take into account the patient perspective. In Medical Decision Making in
Botox over preventive health: health consumers have spoken, delaying diagnoses
Americans are opting for Botox and cosmetic procedures more than colonoscopies and cancer tests, according to a story in Reuters. This trend makes companies like Allergan, makers of Botox and the Lap-Band for gastric surgery, very happy indeed. Plastics and gastric bypass surgeries are back up to pre-recession levels as of 2Q11. However, for companies and providers in other segments of the health care and surgery value-chain, prospects for bounceback in 2011 aren’t as promising. Various indices on consumers’ health care sentiment — such as the Thomson-Reuters Consumer Healthcare Sentiment Index and the EBRI Health Confidence Survey, show U.S. consumers’ perceptions of their ability to
Health information gumbo: peoples’ health searches are mashed-up and increasingly mobile
Health professionals are go-to sources for medical diagnoses, information about prescription drugs and alternative treatments, and recommendations for doctors and hospitals. On the other hand, health information seekers turn to fellow patients, friends and family for emotional support in dealing with health issues, and quick remedies for everyday issues. And increasingly, those health information searches are going mobile, with 17% of U.S. adults having ever used their cell phone to look up health or medical information. This proportion nearly doubles for 18-29 year olds, and is also higher for wealthier people, Latino’s, college graduates, and urbanites. 1 in 10 people with a
The average annual health costs for a U.S. family of four approach $20,000, with employees bearing 40%
Health care costs have doubled in less than nine years for the typical American family of four covered by a preferred provider health plan (PPO). In 2011, that health cost is nearly $20,000; in 2002, it was $9,235, as measured by the 2011 Milliman Medical Index (MMI). To put this in context, The 2011 poverty level for a family of 4 in the 48 contiguous U.S. states is $22,350 The car buyer could purchase a Mini-Cooper with $20,000 The investor could invest $20K to yield $265,353 at a 9% return-on-investment. The MMI increased 7.3% between 2010 and 2011, about the same
Brand “Health:” where is it in the Top 100 most valuable brands?
Apple has supplanted Google as the world’s #1 most valuable brand, worth more brand-wise than Microsoft and Coca-Cola combined (#5 and #6). the other most valuable global brands are IBM, McDonalds, AT&T, Marlboro, China Mobile, and GE. Technology brands have significantly grown in value with consumers allocating more personal disposable income to products like tablet computers and smartphones, even in the face of recessionary economics the world over. Technology companies are now 1/3 of the top 100 brands. Millward Brown, the brand consultancy that is part of WPP, the global communications firm, has conducted the BrandZ top 100 most valuable
ePrescribing continues to challenge physicians – but can be a link for patient engagement
About 1.3 million people in the U.S. experience a medication error each year, which are preventable events that may cause or lead to inappropriate medication use or harm a patient, any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer. Two very common causes of medication errors are illegible handwriting by prescribers and misplaced decimal points on prescription forms. Twenty percent of adverse drug events lead to life-threatening circumstances, according to The Leapfrog Group. The costs of medication errors has been
The new health reform is online and mobile; talking at J. Boye 2011 in Philadelphia
With non-communicable diseases (NCDs) killing two-third’s of the Earth’s residents — not malaria, HIV or other infectious diseases — the World Health Organization calls lifestyle-borne chronic conditions a “slow-motion catastrophe.” The solution for addressing this global challenge isn’t just about deploying more doctors and medical technology in hospitals and bricks-and-mortar institutions. The real health reform is about infrastructure-independent care and feeding that bolsters peoples’ health where they live, work, play and pray, as characterized by the U.S. Surgeon General Dr. Regina Benjamin in the Los Angeles Times on March 13, 2011. Today I’ll be participating on the eHealth track at the J.
Verizon expanding into remote and mobile health for senior living – what it means for healthy aging and medical costs
The announcement that Verizon, the telecommunications giant, will partner with Healthsense, a home health monitoring company, indicates that the adoption of telehealth services beyond project pilots and government-funds required to bolster the market is real. Verizon is upgrading the FiOS network, which it will extend to senior housing and assisted living communities that would use Healthsense’s suite of remote health monitoring, personal emergency response systems, wireless nurse call, and wellness monitoring products. The broadband FiOS network is upgradeable to 100 megabits per second, which would enable the bandwidth required by home health technologies that require high performance and reliable network connectivity. These
The patent cliff coupled with value-based health purchasing makes for declining branded pharma market in the U.S.
Two mega-trends are driving down branded pharmaceutical sales in the U.S.: switches from branded to generic prescription drug products for major chronic conditions; and, the lack of new-new branded Rx products that (could) command higher prices. A down-market picture emerges from The Use of Medicines in the United States: Review of 2010, based on market data analyzed by the IMS Institute for Healthcare Informatics (IMS). While U.S. market growth for pharma overall ranges from 3% to 5%, IMS says, protected Rx brands were negatively impacted through the switch to cheaper generic substitutes. Generics now comprise 78% of pharma market share. The key sentence
Patients’ health activation leads to better outcomes, but providers aren’t as engaging as they should be
Patient engagement improves health outcomes. But deploying patient empowerment and engagement tools involve many challenges, among them: privacy, security, integrity of medical records, liability, and payment. These have prevented health providers – doctors and hospitals – from adopting strategies to more closely engage patients. From the patient’s perspective, though, many patients have project-managed their own approaches to engagement with online and mobile health tools, such as participating in peer-to-peer health social networks, downloading and using mobile health apps, and monitoring calories, weight and sleep through devices like FitBit, Zeo, and the Withings scale. The Institute for Health Technology Transformation (iHT2) published the
Jane joined host Dr. Geeta "Dr. G" Nayyar and colleagues to brainstorm the value of vaccines for public and individual health in this challenging environment for health literacy, health politics, and health citizen grievance. Click onto the Pfizer Value of Vaccines site and you can watch four episodes covering the challenges with adult vaccination, the employer and health plan member's journey to vaccination, reimbursement, and collaborating for proactive prevention.
I'm grateful to be part of the Duke Corporate Education faculty, sharing perspectives on the future of health care with health and life science companies. Once again, I'll be brainstorming the future of health care with a cohort of executives working in a global health care enterprise.
Jane will be working with EU- and UK-based clients in September and October 2026, collaborating with stakeholders in digital health, public/community health, retail health, and growing opportunities for health-at-home. Stay tuned to her updates here on Health Populi on-the-ground as she lives the digital nomadic work-life in Italy, Belgium, the Netherlands, and in London.